Global Celecoxib Capsule Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI09248243

Publication Date:

September 16, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Celecoxib Capsule market size was valued at US$ million in 2023. With growing demand in downstream market, the Celecoxib Capsule is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Celecoxib Capsule market. Celecoxib Capsule are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Celecoxib Capsule. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Celecoxib Capsule market.
Celecoxib, sold under the brand name Celebrex among others, is a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID). It is used to treat the pain and inflammation in osteoarthritis, acute pain in adults, rheumatoid arthritis, ankylosing spondylitis, painful menstruation, and juvenile rheumatoid arthritis. It may also be used to decrease the risk of colorectal adenomas in people with familial adenomatous polyposis. It is taken by mouth. Benefits are typically seen within an hour.
Key Features:
The report on Celecoxib Capsule market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Celecoxib Capsule market. It may include historical data, market segmentation by Type (e.g., 50mg, 100mg), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Celecoxib Capsule market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Celecoxib Capsule market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Celecoxib Capsule industry. This include advancements in Celecoxib Capsule technology, Celecoxib Capsule new entrants, Celecoxib Capsule new investment, and other innovations that are shaping the future of Celecoxib Capsule.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Celecoxib Capsule market. It includes factors influencing customer ' purchasing decisions, preferences for Celecoxib Capsule product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Celecoxib Capsule market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Celecoxib Capsule market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Celecoxib Capsule market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Celecoxib Capsule industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Celecoxib Capsule market.
Market Segmentation:
Celecoxib Capsule market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
50mg
100mg
200mg
400mg
Segmentation by application
Rheumatoid Arthritis
Osteoarthritis
Acute Pain
Musculoskeletal Pain
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer
Teva
Mylan
Apotex
Lupin
HENGRUI MEDICINE

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Celecoxib Capsule Market Size 2019-2030
2.1.2 Celecoxib Capsule Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Celecoxib Capsule Segment by Type
2.2.1 50mg
2.2.2 100mg
2.2.3 200mg
2.2.4 400mg
2.3 Celecoxib Capsule Market Size by Type
2.3.1 Celecoxib Capsule Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Celecoxib Capsule Market Size Market Share by Type (2019-2024)
2.4 Celecoxib Capsule Segment by Application
2.4.1 Rheumatoid Arthritis
2.4.2 Osteoarthritis
2.4.3 Acute Pain
2.4.4 Musculoskeletal Pain
2.4.5 Others
2.5 Celecoxib Capsule Market Size by Application
2.5.1 Celecoxib Capsule Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Celecoxib Capsule Market Size Market Share by Application (2019-2024)
3 Celecoxib Capsule Market Size by Player
3.1 Celecoxib Capsule Market Size Market Share by Players
3.1.1 Global Celecoxib Capsule Revenue by Players (2019-2024)
3.1.2 Global Celecoxib Capsule Revenue Market Share by Players (2019-2024)
3.2 Global Celecoxib Capsule Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Celecoxib Capsule by Regions
4.1 Celecoxib Capsule Market Size by Regions (2019-2024)
4.2 Americas Celecoxib Capsule Market Size Growth (2019-2024)
4.3 APAC Celecoxib Capsule Market Size Growth (2019-2024)
4.4 Europe Celecoxib Capsule Market Size Growth (2019-2024)
4.5 Middle East & Africa Celecoxib Capsule Market Size Growth (2019-2024)
5 Americas
5.1 Americas Celecoxib Capsule Market Size by Country (2019-2024)
5.2 Americas Celecoxib Capsule Market Size by Type (2019-2024)
5.3 Americas Celecoxib Capsule Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Celecoxib Capsule Market Size by Region (2019-2024)
6.2 APAC Celecoxib Capsule Market Size by Type (2019-2024)
6.3 APAC Celecoxib Capsule Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Celecoxib Capsule by Country (2019-2024)
7.2 Europe Celecoxib Capsule Market Size by Type (2019-2024)
7.3 Europe Celecoxib Capsule Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Celecoxib Capsule by Region (2019-2024)
8.2 Middle East & Africa Celecoxib Capsule Market Size by Type (2019-2024)
8.3 Middle East & Africa Celecoxib Capsule Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Celecoxib Capsule Market Forecast
10.1 Global Celecoxib Capsule Forecast by Regions (2025-2030)
10.1.1 Global Celecoxib Capsule Forecast by Regions (2025-2030)
10.1.2 Americas Celecoxib Capsule Forecast
10.1.3 APAC Celecoxib Capsule Forecast
10.1.4 Europe Celecoxib Capsule Forecast
10.1.5 Middle East & Africa Celecoxib Capsule Forecast
10.2 Americas Celecoxib Capsule Forecast by Country (2025-2030)
10.2.1 United States Celecoxib Capsule Market Forecast
10.2.2 Canada Celecoxib Capsule Market Forecast
10.2.3 Mexico Celecoxib Capsule Market Forecast
10.2.4 Brazil Celecoxib Capsule Market Forecast
10.3 APAC Celecoxib Capsule Forecast by Region (2025-2030)
10.3.1 China Celecoxib Capsule Market Forecast
10.3.2 Japan Celecoxib Capsule Market Forecast
10.3.3 Korea Celecoxib Capsule Market Forecast
10.3.4 Southeast Asia Celecoxib Capsule Market Forecast
10.3.5 India Celecoxib Capsule Market Forecast
10.3.6 Australia Celecoxib Capsule Market Forecast
10.4 Europe Celecoxib Capsule Forecast by Country (2025-2030)
10.4.1 Germany Celecoxib Capsule Market Forecast
10.4.2 France Celecoxib Capsule Market Forecast
10.4.3 UK Celecoxib Capsule Market Forecast
10.4.4 Italy Celecoxib Capsule Market Forecast
10.4.5 Russia Celecoxib Capsule Market Forecast
10.5 Middle East & Africa Celecoxib Capsule Forecast by Region (2025-2030)
10.5.1 Egypt Celecoxib Capsule Market Forecast
10.5.2 South Africa Celecoxib Capsule Market Forecast
10.5.3 Israel Celecoxib Capsule Market Forecast
10.5.4 Turkey Celecoxib Capsule Market Forecast
10.5.5 GCC Countries Celecoxib Capsule Market Forecast
10.6 Global Celecoxib Capsule Forecast by Type (2025-2030)
10.7 Global Celecoxib Capsule Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Celecoxib Capsule Product Offered
11.1.3 Pfizer Celecoxib Capsule Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Teva
11.2.1 Teva Company Information
11.2.2 Teva Celecoxib Capsule Product Offered
11.2.3 Teva Celecoxib Capsule Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Teva Main Business Overview
11.2.5 Teva Latest Developments
11.3 Mylan
11.3.1 Mylan Company Information
11.3.2 Mylan Celecoxib Capsule Product Offered
11.3.3 Mylan Celecoxib Capsule Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Mylan Main Business Overview
11.3.5 Mylan Latest Developments
11.4 Apotex
11.4.1 Apotex Company Information
11.4.2 Apotex Celecoxib Capsule Product Offered
11.4.3 Apotex Celecoxib Capsule Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Apotex Main Business Overview
11.4.5 Apotex Latest Developments
11.5 Lupin
11.5.1 Lupin Company Information
11.5.2 Lupin Celecoxib Capsule Product Offered
11.5.3 Lupin Celecoxib Capsule Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Lupin Main Business Overview
11.5.5 Lupin Latest Developments
11.6 HENGRUI MEDICINE
11.6.1 HENGRUI MEDICINE Company Information
11.6.2 HENGRUI MEDICINE Celecoxib Capsule Product Offered
11.6.3 HENGRUI MEDICINE Celecoxib Capsule Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 HENGRUI MEDICINE Main Business Overview
11.6.5 HENGRUI MEDICINE Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂